Article
Phenylketonuria, co‐morbidity, and ageing: A review
1 Nov 2019
Abstract excerpt
Phenylketonuria (PKU) is a metabolic condition which, left untreated, results in severe and irreversible brain damage. Newborn screening and the development of the low phenylalanine (Phe) diet have transformed the outcomes for people with PKU. Those who have benefited from early treatment are now approaching their fifth and sixth decade. It is therefore timely to consider multi-morbidity in PKU and the effects of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
